Home › Trial NCT02504801
Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD
- Trial IDNCT02504801
- StatusUnknown
- PhasePhase 4
- Study typeInterventional
- SponsorXiuyi Zhi
- Enrollment73
- Start date2015-07
- ConditionsPost Operative Complication, Pulmonary · Lung Cancer · COPD
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.